Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

References

Page 1

	Year	Citations
Regression Models and Life-Tables D. R. Cox Journal of the Royal Statistical Society Series B (Statistical Methodology) Regression ModelsReliability EngineeringConditional LikelihoodEngineeringLife Prediction	1972	38.8K
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	38.7K
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren Mason, Martin J. van den Bent, New England Journal of Medicine	2005	21K
Bootstrap Methods: Another Look at the Jackknife B. Efron The Annals of Statistics EngineeringMachine LearningSampling OptimizationStatistical FoundationStatistical Analysis	1979	17.1K
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia, New England Journal of Medicine	2005	7.1K
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents Manel Esteller, Jesús García‐Foncillas, Esther Andion, New England Journal of Medicine	2000	2.2K
Rank Correlation Methods Wassily Hoeffding, M. G. Kendall Econometrica Ranking AlgorithmRank Correlation MethodsLearning To RankStatisticsLow-rank Approximation	1957	1.6K
Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials W.J. Curran, Charles Scott, John Horton, JNCI Journal of the National Cancer Institute	1993	1.3K
Rank Correlation Methods Z. Govindarajulu, Melissa M. Kendall, Jean Dickinson Gibbons Technometrics Ranking AlgorithmRank Correlation MethodsLearning To RankStatisticsLow-rank Approximation	1992	1.1K
Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide Roger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, Journal of Clinical Oncology	2002	812

Page 1